1-Heteroarylsulphonyl-2-imino-imidazolidines
US3941804A · kind A · utility
5Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 1974 |
| Grant date | Mar 2, 1976 |
| Priority date | — |
| Expiry date | Jul 15, 1994 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/34
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the class of 1-heteroarylsulphonyl-2-imino-imidazolidines which are substituted in the 3-position by an aliphatic or cycloaliphatic hydrocarbon radical, especially a cycloalkyl radical, and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties. In particular, they possess hypoglycaemic activity and can be used for the treatment of hyperglycaemia in mammals. A specific embodiment is 1-[5-(2-butyramido-ethyl)-2-thienylsulphonyl]-2-imino-5-cyclohexyl-imidazo lidine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.